Special Issue "Transcription Factors as Therapeutic Targets"
Deadline for manuscript submissions: 31 March 2018
Dr. Takaomi Sanda
Cancer Science Institute of Singapore, National University of Singapore/Department of Medicine, Yong Loo Lin School of Medicine, National University of Singapore
Website | E-Mail
Interests: transcription; transcription factor; enhancer; core regulatory circuit; stem cells; hematopoiesis; acute leukemia; T-cell acute lymphoblastic leukemia; oncogene; TAL1
Deregulation of transcription factor genes are frequently observed in various human diseases, such as cancer. Understanding the molecular pathogenesis, as well as the development of therapeutic approaches, are crucial to further advance the treatment outcome. Although the feasibility of transcription factors as therapeutic targets has long been realized, the development of drugs is still very challenging due to several pharmacological and biological reasons. Therefore, an improved knowledge is necessary to make transcription factors “actionable”. This Special Issue aims to provide a forum for the dissemination of the latest information on new approaches and methods targeting transcription factors, and with methods of testing their success in cancer or other human diseases.
Dr. Takaomi Sanda
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All papers will be peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Molecules is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1800 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- Transcription factor
- Immunological diseases
- Infectious diseases